Cathie Wood acquired 1.4 Million Ionis Pharmaceuticals shares worth $57.1 Million. That's 0.47% of their equity portfolio (37th largest holding). The first Ionis Pharmaceuticals trade was made in Q4 2016. Since then Cathie Wood bought shares twelve more times and sold shares on fifteen occasions. The investor's estimated purchase price is $66.5 Million, resulting in a loss of 14%.